Ana Blazquez-Lozano

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Accelerating biosimilar adoption by empowering hospital pharmacists: a dialogue between emerging markets and European hospital pharmacists.

Accelerating biosimilar adoption by empowering hospital pharmacists: a dialogue between emerging markets and European hospital pharmacists.

Journal: European journal of hospital pharmacy : science and practice
Published: August 05, 2026

[Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma.

[Translated article] Possible severe gastrointestinal toxicity following the first cycle of mirvetuximab soravtansine in a patient with high-grade serous ovarian carcinoma.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: September 10, 2025

The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival.

The Age Factor in Ixekizumab Survival: Older Patients Show Higher Long-Term Treatment Survival.

Journal: Medicina (Kaunas, Lithuania)
Published: September 09, 2025

Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use.

Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use.

Journal: Life (Basel, Switzerland)
Published: April 15, 2025

[Translated article] Vemurafenib for the treatment of BRAF V600 mutated glioblastoma: A case report.

[Translated article] Vemurafenib for the treatment of BRAF V600 mutated glioblastoma: A case report.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: January 23, 2025

Eribulin in metastatic breast cancer: Real world data.

Eribulin in metastatic breast cancer: Real world data.

Journal: Breast disease
Published: December 11, 2023

Dose reduction and toxicity of lenalidomide-dexamethasone in multiple myeloma: A machine-learning prediction model.

Dose reduction and toxicity of lenalidomide-dexamethasone in multiple myeloma: A machine-learning prediction model.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: September 06, 2023

Digital health.

Digital health.

Journal: European journal of hospital pharmacy : science and practice
Published: September 01, 2023

Exacerbation of a thrombotic thrombocytopenic purpura episode linked to different P2Y12 inhibitors in the same patient. Case report.

Exacerbation of a thrombotic thrombocytopenic purpura episode linked to different P2Y12 inhibitors in the same patient. Case report.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 10, 2023

Advanced therapy medicinal products.

Advanced therapy medicinal products.

Journal: European journal of hospital pharmacy : science and practice
Published: March 17, 2023

Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs. Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population.

Real-world Data Study of the Efficacy and Toxicity of Nivolumab vs. Cetuximab and Predictors of Response to Nivolumab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck in a European Population.

Journal: Anticancer research
Published: January 23, 2023

Pharmacotherapeutic management of advanced therapy drugs.

Pharmacotherapeutic management of advanced therapy drugs.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: April 05, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026